ArticleBreast care (Basel, Switzerland)2023

CDK4/6 Inhibitors in Advanced HR+/HER2 - Breast Cancer: A Multicenter Real-World Data Analysis.

Carolin Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.